Effect of Okinawa Propolis on PAK1 Activity, Caenorhabditis elegans Longevity, Melanogenesis, and Growth of Cancer Cells

• Published in: Journal of agricultural and food chemistry 2016-07, Vol.64 (27), p.5484-5489
• Main Authors: Taira, Nozomi, Nguyen, Binh Cao Quan, Be Tu, Pham Thi, Tawata, Shinkichi
• Format: Article
• Language: English
• Subjects: Animals; Caenorhabditis elegans - drug effects; Caenorhabditis elegans - growth & development; Cell Proliferation - drug effects; Humans; Japan; Longevity - drug effects; Melanins - metabolism; Neoplasms - enzymology; Neoplasms - physiopathology; p21-Activated Kinases - antagonists & inhibitors; p21-Activated Kinases - metabolism; Propolis - chemistry
• ISSN: 0021-8561; 1520-5118
• DOI: 10.1021/acs.jafc.6b01785

Propolis from different areas has been reported to inhibit oncogenic/aging kinase PAK1, which is responsible for a variety of conditions, including cancer, longevity, and melanogenesis. Here, a crude extract of Okinawa propolis (OP) was tested against PAK1 activity, Caenorhabditis elegans (C. elegans) longevity, melanogenesis, and growth of cancer cells. We found that OP blocks PAK1 and exhibits anticancer activity in the A549 cell (human lung cancer cell) line with IC50 values of 6 μg/mL and 12 μg/mL, respectively. Most interestingly, OP (1 μg/mL) significantly reduces reproduction and prolongs the lifespan of C. elegans by activating the HSP-16.2 gene, as shown in the PAK1-deficient strain. Furthermore, OP inhibits melanogenesis in a melanoma cell line (B16F10) by downregulating intracellular tyrosinase activity with an IC50 of 30 μg/mL. Our results suggest that OP demonstrated a life span extending effect, C. elegans, anticancer, and antimelanogenic effects via PAK1 inactivation; therefore, this can be a potent natural medicinal supplement against PAK1-dependent diseases.